Phase III Study of Pharos Vitesse Neurovascular Stent System Compared to Best Medical Therapy for the Treatment of Ischemic Disease
The main objective of this study is to prospectively evaluate the safety, probable benefit, and effectiveness of the PHAROS Vitesse Neurovascular Stent System in a multicenter, randomized clinical trial.
A secondary objective of this study is to evaluate the impact of stenting in the neurovasculature to treat cerebral ischemia on other outcomes such as hospital length of stay, charges, and costs.
100 Clinical Results associated with Codman & Shurtleff, Inc. /Surgical Instruments Business/
0 Patents (Medical) associated with Codman & Shurtleff, Inc. /Surgical Instruments Business/
100 Deals associated with Codman & Shurtleff, Inc. /Surgical Instruments Business/
100 Translational Medicine associated with Codman & Shurtleff, Inc. /Surgical Instruments Business/